Literature DB >> 26986622

Pharmacist medication reviews to improve safety monitoring in primary care patients.

Casey E Gallimore1, Dimmy Sokhal1, Elizabeth Zeidler Schreiter2, Amanda R Margolis1.   

Abstract

OBJECTIVE: Patients prescribed psychotropic medications within primary care are at risk of suboptimal monitoring. It is unknown whether pharmacists can improve medication safety through targeted monitoring of at risk populations. Access Community Health Centers implemented a quality improvement pilot project that included pharmacists on an integrated care team to provide medication reviews for patients. Aims were to determine whether inclusion of a pharmacist performing medication reviews within a primary care behavioral health (PCBH) practice is feasible and facilitates safe medication use.
METHOD: Pharmacists performed medication reviews of the electronic health record for patients referred for psychiatry consultation. Reviews were performed 1-3 months following consultation and focused on medications with known suboptimal monitoring rates. Reviews were documented within the EHR and routed to the primary care provider. Primary outcome measures were change in percentage up-to-date on monitoring and AIMS assessment, and at risk of experiencing drug interaction(s) between baseline and 3 months postreview. Secondary outcome was provider opinion of medication reviews collected via electronic survey.
RESULTS: Reviews were performed for 144 patients. Three months postreview, percentage up-to-date on recommended monitoring increased 18% (p = .0001), at risk for drug interaction decreased 20% (p < .0001), and up-to-date on AIMS decreased 12% (p = .2113). The majority of surveyed providers wanted medication reviews to continue.
CONCLUSION: Pharmacist population-level monitoring within an integrated care team is feasible and associated with improved safety monitoring of psychotropic medications. Results identify key areas for improvement that other clinics considering integration of similar pharmacy services should consider. (PsycINFO Database Record (c) 2016 APA, all rights reserved).

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26986622     DOI: 10.1037/fsh0000185

Source DB:  PubMed          Journal:  Fam Syst Health        ISSN: 1091-7527            Impact factor:   1.950


  4 in total

1.  Impact of pharmacists on outcomes for patients with psychiatric or neurologic disorders.

Authors:  Amy Werremeyer; Jolene Bostwick; Carla Cobb; Tera D Moore; Susie H Park; Cristofer Price; Jerry McKee
Journal:  Ment Health Clin       Date:  2020-11-05

2.  Psychotropic medication use patterns in home-based primary care: A scoping review.

Authors:  Nina Vadiei; Carol L Howe; Beth Zerr; Nicholas Ladziak; Mindy J Fain; Jeannie K Lee
Journal:  Ment Health Clin       Date:  2020-09-30

3.  Application of Novel Pharmacists' Risk in Pharmacotherapy (PHARIPH) Scale for Identification of Factors Affecting the Safety of Hospital Pharmacotherapy-An Observational Pilot Study.

Authors:  Olga Fedorowicz; Łukasz Rypicz; Anna Wiela-Hojeńska; Ewa Jaźwińska-Tarnawska; Izabela Witczak
Journal:  Int J Environ Res Public Health       Date:  2022-01-25       Impact factor: 3.390

4.  Association of Focused Medication Review With Optimization of Psychotropic Drug Prescribing: A Systematic Review and Meta-analysis.

Authors:  Rory Sheehan; André Strydom; Emma Brown; Louise Marston; Angela Hassiotis
Journal:  JAMA Netw Open       Date:  2018-10-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.